Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

Soft drinks with added sugar might increase a person's risk of type 2 diabetes by affecting their gut microbiome, new ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

24, 2025 (HealthDay News) -- People can reverse their type 2 diabetes through a combination of calorie cutting and medication ...

Developing regions such as Sub-Saharan Africa, Latin America, and the Caribbean showed particularly alarming numbers ...